Abstract
Background: Amyloid beta (Aβ) accumulates in the human brain in an age-dependent manner during normal aging. However, Aβ accumulation has not been observed in rodents during normal aging. Tree shrews, the experimental animals studied here, are as small as rats but have a longer life span than rodents.
Methods: We investigated Aβ accumulations in the brains of young and aged tree shrews by amyloid histochemistry and immunohistochemistry using antibodies to Aβ-42, Aβ-40, Aβ-16 and amyloid precursor protein (APP).
Results: In the brain of young tree shrews, there were no Aβ- immunoreactive (-ir) and APP-ir profiles. In the brains of aged tree shrews, Aβ-42-ir neuronal profiles were observed in the cortex, subiculum, basal ganglia, mammillary body and hypothalamus, but there were only a few weak Congo red-positive amyloid deposits. Aβ-42-, Aβ-40-, Aβ-16- and APP-ir blood vessels were observed.
Conclusions: An early stage of amyloid accumulation occurs in the brains of aged tree shrews, indicating that this animal may be a good model for studying the start of Aβ accumulation.
Keywords: Normal aging, blood vessel, amyloid deposit, Congo red, Alzheimer’s disease, Tupai belangeri.
Current Aging Science
Title: Amyloid Beta (Aβ) Protein- and Amyloid Precursor Protein (APP)- Immunoreactive Structures in the Brains of Aged Tree Shrews
Volume: 3 Issue: 3
Author(s): Akiko Yamashita, Eberhard Fuchs, Masato Taira and Motoharu Hayashi
Affiliation:
Keywords: Normal aging, blood vessel, amyloid deposit, Congo red, Alzheimer’s disease, Tupai belangeri.
Abstract: Background: Amyloid beta (Aβ) accumulates in the human brain in an age-dependent manner during normal aging. However, Aβ accumulation has not been observed in rodents during normal aging. Tree shrews, the experimental animals studied here, are as small as rats but have a longer life span than rodents.
Methods: We investigated Aβ accumulations in the brains of young and aged tree shrews by amyloid histochemistry and immunohistochemistry using antibodies to Aβ-42, Aβ-40, Aβ-16 and amyloid precursor protein (APP).
Results: In the brain of young tree shrews, there were no Aβ- immunoreactive (-ir) and APP-ir profiles. In the brains of aged tree shrews, Aβ-42-ir neuronal profiles were observed in the cortex, subiculum, basal ganglia, mammillary body and hypothalamus, but there were only a few weak Congo red-positive amyloid deposits. Aβ-42-, Aβ-40-, Aβ-16- and APP-ir blood vessels were observed.
Conclusions: An early stage of amyloid accumulation occurs in the brains of aged tree shrews, indicating that this animal may be a good model for studying the start of Aβ accumulation.
Export Options
About this article
Cite this article as:
Yamashita Akiko, Fuchs Eberhard, Taira Masato and Hayashi Motoharu, Amyloid Beta (Aβ) Protein- and Amyloid Precursor Protein (APP)- Immunoreactive Structures in the Brains of Aged Tree Shrews, Current Aging Science 2010; 3 (3) . https://dx.doi.org/10.2174/1874609811003030230
DOI https://dx.doi.org/10.2174/1874609811003030230 |
Print ISSN 1874-6098 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-6128 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Diagnostics of Fine Needle Aspiration for the Presurgical Screening of Thyroid Nodules
Current Genomics Altered CYP Expression and Function in Response to Dietary Factors: Potential Roles in Disease Pathogenesis
Current Drug Metabolism Ketamine as Antidepressant? Current State and Future Perspectives
Current Neuropharmacology The Neurotrophic and Antiangiogenic Functions of PEDF: A Reflection of its Variable Phosphorylation States
Current Genomics Tumor Control by Manipulation of the Human Anti-Apoptotic Survivin Gene
Current Cancer Therapy Reviews Deleted in Colorectal Cancer (DCC) Pathfinding: Axon Guidance Gene Finally Turned Tumor Suppressor
Current Drug Targets Ribosome-inactivating Proteins from Root Tubers and Seeds of Trichosan-thes kirilowii and Other Trichosanthes Species
Protein & Peptide Letters Apoptosis and Apoptosis-Based Therapy in Lung Cancer
Anti-Cancer Agents in Medicinal Chemistry Editorial [Hot Topic: Prospective Clinical Role for Anticancer Garlic Organosulfur Compounds (Guest Editor: Hassan T. Hassan)]
Anti-Cancer Agents in Medicinal Chemistry Metastatic Melanoma in a Young Woman Treated with TNF-Alpha Inhibitor for Psoriatic Arthritis: A Case Report
Current Drug Safety Recent Evidence on the Role of Dietary PUFAs in Cancer Development and Prevention
Current Medicinal Chemistry The Role of Notch Signaling Pathway in Epithelial-Mesenchymal Transition (EMT) During Development and Tumor Aggressiveness
Current Drug Targets Natural Products as Modulators of Spermatogenesis: The Search for a Male Contraceptive
Current Molecular Pharmacology Aldehyde Dehydrogenase as a Marker for Stem Cells
Current Stem Cell Research & Therapy PET and SPECT Radiotracers to Assess Function and Expression of ABC Transporters In Vivo
Current Drug Metabolism Prostatic Tumor Stroma: A Key Player in Cancer Progression
Current Cancer Drug Targets A Review of Gene Expression Profiling of Human Embryonic Stem Cell Lines and their Differentiated Progeny
Current Stem Cell Research & Therapy Introduction: MMPs, ADAMs/ADAMTSs Research Products to Achieve Big Dream
Anti-Cancer Agents in Medicinal Chemistry Glycogen Synthase Kinase-3 Beta; A New Target in Pancreatic Cancer?
Current Cancer Drug Targets Bladder Cancer: Molecular Determinants of Personalized Therapy
Current Drug Targets